REQUEST A DEMO
Total
USD $0.00
Search more companies

Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pars Farmed Zagros Pharmaceutical Company is an Iranian company producing diversified chemical and pharmaceutical animal products. The company was established in 1983 and is headquartered in Tehran. It offers a range of veterinary products, among them anti-biotics, disinfectants, growth promoters and vitamins. The products are offered in various dosage forms, such as powder, granules, oral solutions and tablets.

Legal Address
18 Km Of Makhsous Karaj Road, Daroupakhsh Street, Pharmaceutical Factories - The Second Door Of Houses
Tehran; Tehran; Postal Code: 1397116396

Contact Details: Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock report to view the information.

Website: http://www.zagrospharmed.com

Basic Information
Total Employees:
Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock report to view the information.
Incorporation Date:
1983
Key Executives
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
1.2%
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
79.25%
Total operating revenue
79.25%
Operating profit (EBIT)
136.46%
EBITDA
131.59%
Net Profit (Loss) for the Period
178.07%
Total assets
61.61%
Total equity
71.27%
Operating Profit Margin (ROS)
11.08%
Net Profit Margin
11.52%
Return on Equity (ROE)
22.06%
Debt to Equity Ratio
-6.34%
Quick Ratio
0.15%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?